{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:28:20Z","timestamp":1780421300225,"version":"3.54.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.autrev.2011.05.006","type":"journal-article","created":{"date-parts":[[2011,5,24]],"date-time":"2011-05-24T21:46:25Z","timestamp":1306273585000},"page":"159-162","source":"Crossref","is-referenced-by-count":21,"title":["A clear look at the neuroimmunology of multiple sclerosis and beyond"],"prefix":"10.1016","volume":"11","author":[{"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilhard","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe K.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.05.006_bb0005","series-title":"Potentials and limitations of current and emerging immunotherapies","first-page":"1","volume":"255 Suppl. 6","year":"2008"},{"key":"10.1016\/j.autrev.2011.05.006_bb0010","series-title":"Cognitive and neuropsychological disorders in neuroimmunological diseases","first-page":"II1","volume":"254 Suppl 2","year":"2007"},{"key":"10.1016\/j.autrev.2011.05.006_bb0015","series-title":"Intravenous immunoglobulins in neurological diseases","first-page":"V1","volume":"253 Suppl. 5","year":"2006"},{"key":"10.1016\/j.autrev.2011.05.006_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.58.1.136","article-title":"Prevalence estimates for ms in the United States and evidence of an increasing trend for women","volume":"58","author":"Noonan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.006_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2007-1019126","article-title":"Epidemiology of multiple sclerosis: from risk factors to prevention","volume":"28","author":"Ascherio","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1468-1331.2006.01342.x","article-title":"The epidemiology of multiple sclerosis in europe","volume":"13","author":"Pugliatti","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0040","doi-asserted-by":"crossref","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","article-title":"Defining and analyzing geoepidemiology and human autoimmunity","volume":"34","author":"Shapira","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0045","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2009.12.007","article-title":"Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice","volume":"35","author":"Behrens","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaut.2009.02.016","article-title":"Sex hormones modulate the effects of leflunomide on cytokine production by cultures of differentiated monocyte\/macrophages and synovial macrophages from rheumatoid arthritis patients","volume":"32","author":"Cutolo","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0060","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000218309.01322.5c","article-title":"Costs and quality of life in multiple sclerosis: a cross-sectional study in the united states","volume":"66","author":"Kobelt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.006_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/erp.10.34","article-title":"Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis","volume":"10","author":"Dunn","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.autrev.2011.05.006_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12016-009-8141-2","article-title":"Challenges for the autoimmunologist","volume":"38","author":"Matthias","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","article-title":"The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity","volume":"31","author":"Shoenfeld","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.autrev.2010.09.020","article-title":"The role of autoimmunologists in investigating and treating autoimmune disorders","volume":"10","author":"Barabas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0085","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/ern.10.116","article-title":"Contribution of genetic, epigenetic and transcriptomic differences to twin discordance in multiple sclerosis","volume":"10","author":"Handunnetthi","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.autrev.2011.05.006_bb0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.1156409","article-title":"Genetic mapping in human disease","volume":"322","author":"Altshuler","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.autrev.2011.05.006_bb0095","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ng.396","article-title":"Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20","volume":"41","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.05.006_bb0100","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddp120","article-title":"Pathway and network-based analysis of genome-wide association studies in multiple sclerosis","volume":"18","author":"Baranzini","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.05.006_bb0105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/ddn388","article-title":"Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis","volume":"18","author":"Baranzini","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.05.006_bb0110","doi-asserted-by":"crossref","first-page":"e3490","DOI":"10.1371\/journal.pone.0003490","article-title":"Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms","volume":"3","author":"Comabella","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.05.006_bb0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/bfgp\/elr004","article-title":"Genome-wide association studies in multiple sclerosis: lessons and future prospects","volume":"10","author":"Kemppinen","year":"2011","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.autrev.2011.05.006_bb0120","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jaci.2009.10.071","article-title":"Genetics of allergic disease","volume":"125","author":"Holloway","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.ejhg.5201818","article-title":"Meta-analysis of genome-wide linkage studies for multiple sclerosis, using an extended GSMA method","volume":"15","author":"Hermanowski","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2011.05.006_bb0130","first-page":"S5","article-title":"Genetic background of multiple sclerosis","volume":"S1","author":"Sadovnick","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.autrev.2009.02.011","article-title":"Vitamin D. The alternative hypothesis","volume":"8","author":"Albert","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2009.05.001","article-title":"The importance of inflammation and vitamin D status in sle-associated osteoporosis","volume":"9","author":"Alele","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2009.02.002","article-title":"Impact of vitamin D receptor activity on experimental autoimmune prostatitis","volume":"32","author":"Motrich","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2010.11.006","article-title":"Vitamin D insufficiency in a large MCTD population","volume":"10","author":"Hajas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.autrev.2010.02.011","article-title":"Vitamin D and autoimmune rheumatologic disorders","volume":"9","author":"Pelajo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2009.02.009","article-title":"The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis","volume":"8","author":"Smolders","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2010.06.009","article-title":"Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice","volume":"9","author":"Souberbielle","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2009.01.017","article-title":"Preventing and curing multiple sclerosis by controlling Epstein\u2013Barr virus infection","volume":"8","author":"Pender","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneurol.2010.91","article-title":"Multiple sclerosis genetics\u2014is the glass half full, or half empty?","volume":"6","author":"Oksenberg","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.57","article-title":"Gene set analysis of SNP data: benefits, challenges, and future directions","volume":"19","author":"Fridley","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2011.05.006_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","article-title":"The epigenetics of autoimmunity","volume":"8","author":"Meda","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0190","doi-asserted-by":"crossref","first-page":"J307","DOI":"10.1016\/j.jaut.2009.11.019","article-title":"The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution","volume":"34","author":"Hemminki","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.autrev.2009.02.006","article-title":"Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes","volume":"8","author":"Richer","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaut.2009.09.001","article-title":"Environmental triggers of autoimmune thyroiditis","volume":"33","author":"Burek","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0205","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2009.01.008","article-title":"MicroRNAs: novel regulators of immunity","volume":"8","author":"Carissimi","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0215","first-page":"S10","article-title":"MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"S1","author":"Thamilarasan","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0220","article-title":"MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response","volume":"10","author":"Iborra","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0230","doi-asserted-by":"crossref","first-page":"e14176","DOI":"10.1371\/journal.pone.0014176","article-title":"A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis","volume":"5","author":"Riveros","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2011.05.006_bb0235","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"Microrna profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47","volume":"132","author":"Junker","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2011.05.006_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2011.03.052","article-title":"Pathophysiology of translational regulation by microRNAs in multiple sclerosis","volume":"585","author":"Junker","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2011.05.006_bb0245","first-page":"S49","article-title":"Autoantibody diagnostics in clinical practice","volume":"S1","author":"Conrad","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0250","first-page":"22","article-title":"Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis","volume":"S1","author":"Hecker","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","article-title":"Novel autoantibody markers for early and seronegative rheumatoid arthritis","volume":"36","author":"Somers","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0260","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.autrev.2009.02.001","article-title":"Multiplexing approaches for autoantibody profiling in multiple sclerosis","volume":"8","author":"Somers","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0265","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1073\/pnas.0503178102","article-title":"An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis","volume":"102","author":"Lolli","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.05.006_bb0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nm0105-13","article-title":"Simple test for multiple sclerosis","volume":"11","author":"Papini","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2011.05.006_bb0275","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","article-title":"Anti-topoisomerase I autoantibodies in systemic sclerosis","volume":"8","author":"Czompoly","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0280","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.autrev.2010.09.017","article-title":"Immunogenetics of systemic sclerosis","volume":"10","author":"Dieude","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0285","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2010.09.008","article-title":"Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"10","author":"Galluccio","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.autrev.2010.09.009","article-title":"The needs of patients with systemic sclerosis\u2014what are the difficulties encountered?","volume":"10","author":"Godard","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0295","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","article-title":"Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis","volume":"35","author":"Arora-Singh","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0305","first-page":"S68","article-title":"Autoimmune blistering diseases of the skin","volume":"S1","author":"Sticherling","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0310","first-page":"S9","article-title":"Immune-mediated central nervous system diseases: A review of nosological classification and clinical features","volume":"S1","author":"Zettl","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0315","first-page":"S33","article-title":"Autoimmune diseases of the peripheral nervous system","volume":"S1","author":"Kieseier","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0320","first-page":"S38","article-title":"Autoimmune disorders affecting both the central and peripheral nervous system","volume":"S1","author":"Kamm","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaut.2009.12.004","article-title":"Peripherin-IgG association with neurologic and endocrine autoimmunity","volume":"34","author":"Chamberlain","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0330","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.autrev.2009.02.013","article-title":"Myelin peptides in multiple sclerosis","volume":"8","author":"Grau-Lopez","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0335","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological aspects of chronic fatigue syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0340","first-page":"S45","article-title":"Pathogenesis and therapies of immune-mediated myopathies","volume":"S1","author":"Dalakas","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0345","doi-asserted-by":"crossref","first-page":"A330","DOI":"10.1016\/j.autrev.2009.11.006","article-title":"The geoepidemiology of autoimmune muscle disease","volume":"9","author":"Prieto","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0350","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.autrev.2009.12.005","article-title":"Polymyositis, dermatomyositis and malignancy: a further intriguing link","volume":"9","author":"Zampieri","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0355","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.autrev.2008.11.008","article-title":"The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies","volume":"8","author":"de Salles Painelli","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0360","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","article-title":"Characterization of regulatory T cells in patients with dermatomyositis","volume":"35","author":"Antiga","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.05.006_bb0365","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2011.05.006_bb0370","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1474-4422(08)70110-8","article-title":"Getting specific: monoclonal antibodies in multiple sclerosis","volume":"7","author":"Lutterotti","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0375","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.0b013e3181fb3676","article-title":"Therapeutic options in multiple sclerosis: five new things","volume":"75","author":"Miravalle","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2011.05.006_bb0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nri2747","article-title":"Strategies and challenges for the next generation of therapeutic antibodies","volume":"10","author":"Beck","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0385","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri2761","article-title":"Therapeutic antibodies for autoimmunity and inflammation","volume":"10","author":"Chan","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2011.05.006_bb0390","first-page":"S54","article-title":"Immunization of the adult immunocompromised host","volume":"S1","author":"L\u00f6bermann","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0395","first-page":"S61","volume":"S1","author":"Flachenecker","year":"2011","journal-title":"Autoimmune diseases and rehabilitation. Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0400","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.autrev.2010.04.001","article-title":"Evidence for prescribing exercise as treatment in pediatric rheumatic diseases","volume":"9","author":"Gualano","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.05.006_bb0405","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.autrev.2009.08.005","article-title":"Psychological stress in rheumatoid arthritis patients: a comparative Polish\u2013German study: summary of the current conceptualization of the role of stress in rheumatoid arthritis","volume":"9","author":"Bugajska","year":"2010","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721100108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721100108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T14:00:42Z","timestamp":1543759242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721100108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S156899721100108X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.05.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}